Preclinical studies in pancreatic cancer models demonstrated that the hyaluronidase PEGPH20, besides increasing CD8+ T cell infiltration as stated before, increases chemotherapy effectiveness (451). This evidence concerns the gene CD8A and pancreatic neoplasm.